163759-40-8

Basic information

• Product Name: methyl 2,3,5-tris-O-(2,4-dichlorobenzyl)-β-D-ribofuranoside
• Synonyms: methyl 2,3,5-tris-O-(2,4-dichlorobenzyl)-β-D-ribofuranoside
• CAS NO: 163759-40-8
• Molecular Weight: 641.203
• Mol File: 163759-40-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 667.9±55.0 °C(Predicted)
• Density: 1.47±0.1 g/cm3(Predicted)
• CAS DataBase Reference: methyl 2,3,5-tris-O-(2,4-dichlorobenzyl)-β-D-ribofuranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2,3,5-tris-O-(2,4-dichlorobenzyl)-β-D-ribofuranoside(163759-40-8)
• EPA Substance Registry System: methyl 2,3,5-tris-O-(2,4-dichlorobenzyl)-β-D-ribofuranoside(163759-40-8)

Safety Data

• Hazardous Substances Data: 163759-40-8(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 50-69-1 D-ribose 
• 94-99-5 2,4-Dichlorobenzyl chloride 
• 7473-45-2 1-O-methyl-D-ribofuranose 
• 532-20-7 D-Ribose 
• 1824-96-0 methyl ribofuranoside 

Downstream Products

• 55073-81-9 3-[methyl α-D-arabinofuranosid-2-yl]adenine 
• 1312805-14-3 4-chloro-7-[methyl 3,5-bis-O-(2,4-dichlorobenzyl)-α-D-arabinofuranosid-2-yl]-7H-pyrrolo[2,3-d]pyrimidine 
• 1312805-16-5 9-[methyl 3,5-bis-O-(2,4-dichlorobenzyl)-α-D-arabinofuranosid-2-yl]adenine 
• 1312805-18-7 4-amino-7-[methyl 3,5-bis-O-(2,4-dichlorobenzyl)-α-D-arabinofuranosid-2-yl]-7H-pyrrolo[2,3-d]pyrimidine 
• 1312805-20-1 7-[methyl 3,5-bis-O-(2,4-dichlorobenzyl)-α-D-arabinofuranosid-2-yl]-4-methoxy-7H-pyrrolo[2,3-d]pyrimidine 
• 163759-41-9 3,5-bis-O-(2,4-dichlorophenylmethyl)-1-O-methyl-β-D-ribofuranose 
• 163759-88-4 Diisopropyl-phosphoramidous acid (2R,3R,4R,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-((S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester 
• 163759-71-5 3-Benzyloxymethyl-1-[(2R,3R,4R,5R)-4-(2,4-dichloro-benzyloxy)-5-(2,4-dichloro-benzyloxymethyl)-3-((S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 163759-73-7 3-Benzyloxymethyl-1-[(2R,3R,4R,5R)-4-(2,4-dichloro-benzyloxy)-5-(2,4-dichloro-benzyloxymethyl)-3-((R)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 168427-93-8 1-[(2R,3R,4R,5R)-4-(2,4-Dichloro-benzyloxy)-5-(2,4-dichloro-benzyloxymethyl)-3-((S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 168427-92-7 1-[(2R,3R,4R,5R)-4-(2,4-Dichloro-benzyloxy)-5-(2,4-dichloro-benzyloxymethyl)-3-((R)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 163878-66-8 Diisopropyl-phosphoramidous acid (2R,3R,4R,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-((R)-3-hexadecyloxy-2-methoxy-propoxy)-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester 
• 163759-85-1 Diisopropyl-phosphoramidous acid (2R,3R,4R,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-{2-[2-(2-decyloxy-ethoxy)-ethoxy]-ethoxy}-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester 
• 168427-57-4 3-Benzyloxymethyl-1-[(2R,3R,4R,5R)-4-(2,4-dichloro-benzyloxy)-5-(2,4-dichloro-benzyloxymethyl)-3-((R)-2-hydroxy-3-octadecyloxy-propoxy)-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 

Relevant articles and documents

Discovery of 2'-α-C-Methyl-2'-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus

2′-α-C-Methyl-2′-β-C-fluorouridine and its phosphoramidate prodrugs were synthesized and evaluated for their inhibitory activity against HCV. The structure?activity relationship analysis of the phosphoramidate moiety found that 17m, 17q, and 17r exhibit potent activities against HCV, with EC50 values of 1.82 ± 0.19, 0.88 ± 0.12, and 2.24 ± 0.22 μM, respectively. The docking study revealed that the recognition of the 2′-β-F by Arg158, 3′-OH by N291, and the Watson?Crick pairing with the template allowed 23 to form the in-line conformation necessary for its incorporation into the viral RNA chain.

Nucleoside derivatives for treating hepatitis C virus infection

Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus.

38. A new access to 2'-O-alkylated ribonucleosides and properties of 2'-O-alkylated oligoribonucleotides

A general access to 2'-O-alkylated ribonucleosides using the key intermediate 5 is presented. The incorporation of 2'-O-'ethyleneglycol'- and 2'-O-'glycerol'-substituted (i.e., 2'-O-(2-hydroxyethyl)- and 2'-O-(2,3-dihydroxypropyl)-substituted) ribonucleosides into oligonucleotides affords a new generation of oligonucleotides with high affinity for RNA, high specificity, and increased nuclease resistance.